Literature DB >> 20151130

Predictors of mortality in skin and soft-tissue infections caused by Vibrio vulnificus.

Tsai-Nung Kuo Chou1, Wai-Nang Chao, Cheng Yang, Ruey-Hong Wong, Kwo-Chang Ueng, Shiuan-Chih Chen.   

Abstract

BACKGROUND: Vibrio vulnificus infection can progress rapidly in skin or soft tissue, and it is potentially life-threatening. The purpose of the present study was to explore the predictors of mortality in patients with V. vulnificus infections of skin or soft tissue.
METHODS: The medical records of 119 consecutive patients aged > or =18 years, hospitalized for V. vulnificus infections of skin or soft tissue between January 2000 and December 2007 were reviewed. Co-morbidities, clinical manifestations, laboratory studies, treatments, and outcomes were analyzed. Multiple logistic regression with the exact method was performed.
RESULTS: The mean age of the patients was 63.7 +/- 12.0 years. Twenty-four patients died, yielding an overall case fatality rate of 20%. Of the 24 deaths, 20 (83%) occurred within 72 h after hospital admission. Of 119 patients, 45 patients had primary septicemia, and 74 patients had wound infection. Multivariate analysis revealed that the following factors were associated with mortality: hemorrhagic bullous skin lesions/necrotizing fasciitis (p = 0.003), primary septicemia (p = 0.042), a greater organ dysfunction and/or infection score (p = 0.005), absence of leukocytosis (p = 0.0001), and hypoalbuminemia (p = 0.003). Treatment with surgical intervention plus antibiotics (p = 0.038) and surgical intervention within 24 h after admission (p = 0.017) were protective factors.
CONCLUSIONS: This study demonstrates that the presence of hemorrhagic bullous skin lesions/necrotizing fasciitis, primary septicemia, a greater severity-of-illness, absence of leukocytosis, and hypoalbuminemia were the significant risk factors for mortality in these patients. Moreover, patients treated with surgery plus antibiotics, especially those receiving a prompt surgical evaluation within 24 h after hospital admission, may have a better prognosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20151130     DOI: 10.1007/s00268-010-0455-y

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  34 in total

1.  Prognostic factors and antibiotics in Vibrio vulnificus septicemia.

Authors:  Jien-Wei Liu; Ing-Kit Lee; Hung-Jen Tang; Wen-Chien Ko; Hsin-Chun Lee; Yung-Ching Liu; Po-Ren Hsueh; Yin-Ching Chuang
Journal:  Arch Intern Med       Date:  2006-10-23

2.  Toxic and enzymatic activities of Vibrio vulnificus biotype 2 with respect to host specificity.

Authors:  E G Biosca; C Amaro
Journal:  Appl Environ Microbiol       Date:  1996-07       Impact factor: 4.792

3.  In vitro and in vivo activities of newer fluoroquinolones against Vibrio vulnificus.

Authors:  Hung-Jen Tang; Ming-Chung Chang; Wen-Chien Ko; Kun-Yen Huang; Chih-Lung Lee; Yin-Ching Chuang
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

Review 4.  Septic shock.

Authors:  Djillali Annane; Eric Bellissant; Jean-Marc Cavaillon
Journal:  Lancet       Date:  2005 Jan 1-7       Impact factor: 79.321

5.  Survival of Vibrio vulnificus in whole blood from patients with chronic liver diseases: association with phagocytosis by neutrophils and serum ferritin levels.

Authors:  L I Hor; T T Chang; S T Wang
Journal:  J Infect Dis       Date:  1999-01       Impact factor: 5.226

6.  Vibrio vulnificus. Man and the sea.

Authors:  J M Johnston; S F Becker; L M McFarland
Journal:  JAMA       Date:  1985-05-17       Impact factor: 56.272

7.  Inflammatory cytokine response to Vibrio vulnificus elicited by peripheral blood mononuclear cells from chronic alcohol users is associated with biomarkers of cellular oxidative stress.

Authors:  Jan L Powell; Kathy A Strauss; Cynthia Wiley; Min Zhan; J Glenn Morris
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

8.  Vibrio vulnificus wound infections from the Mississippi Gulf coastal waters: June to August 1993.

Authors:  A D Penman; D C Lanier; W T Avara; K E Canant; J W DeGroote; B T Brackin; M M Currier; R L Hotchkiss
Journal:  South Med J       Date:  1995-05       Impact factor: 0.954

9.  Cutaneous injury and Vibrio vulnificus infection.

Authors:  P H Chung; S K Chuang; Thomas Tsang; Lai Wai-man; Raymond Yung; Janice Lo
Journal:  Emerg Infect Dis       Date:  2006-08       Impact factor: 6.883

Review 10.  Vibrio vulnificus in Taiwan.

Authors:  Po-Ren Hsueh; Ching-Yih Lin; Hung-Jen Tang; Hsin-Chun Lee; Jien-Wei Liu; Yung-Ching Liu; Yin-Ching Chuang
Journal:  Emerg Infect Dis       Date:  2004-08       Impact factor: 6.883

View more
  13 in total

1.  Prognostic factor of mortality and its clinical implications in patients with necrotizing fasciitis caused by Vibrio vulnificus.

Authors:  Yao-Chou Lee; Lien-I Hor; Haw-Yen Chiu; Jing-Wei Lee; Shyh-Jou Shieh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-14       Impact factor: 3.267

Review 2.  Hypoalbuminemia as Surrogate and Culprit of Infections.

Authors:  Christian J Wiedermann
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

3.  Correlations between Clinical Features and Mortality in Patients with Vibrio vulnificus Infection.

Authors:  Hong Zhao; Lichen Xu; Huihui Dong; Jianhua Hu; Hainv Gao; Meifang Yang; Xuan Zhang; Xiaoming Chen; Jun Fan; Weihang Ma
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

4.  pH level as a marker for predicting death among patients with Vibrio vulnificus infection, South Korea, 2000-2011.

Authors:  Na Ra Yun; Dong-Min Kim; Jun Lee; Mi Ah Han
Journal:  Emerg Infect Dis       Date:  2015-02       Impact factor: 6.883

5.  Necrotizing fasciitis: risk factors of mortality.

Authors:  Patcharin Khamnuan; Wilaiwan Chongruksut; Kijja Jearwattanakanok; Jayanton Patumanond; Suttida Yodluangfun; Apichat Tantraworasin
Journal:  Risk Manag Healthc Policy       Date:  2015-02-16

6.  Small-molecule inhibitor of HlyU attenuates virulence of Vibrio species.

Authors:  Zee-Won Lee; Byoung Sik Kim; Kyung Ku Jang; Ye-Ji Bang; Suhyeon Kim; Nam-Chul Ha; Young Hyun Jung; Hyun Jik Lee; Ho Jae Han; Jong-Seo Kim; Jeesoo Kim; Pramod K Sahu; Lak Shin Jeong; Myung Hee Kim; Sang Ho Choi
Journal:  Sci Rep       Date:  2019-03-13       Impact factor: 4.379

Review 7.  The X chromosome and sex-specific effects in infectious disease susceptibility.

Authors:  Haiko Schurz; Muneeb Salie; Gerard Tromp; Eileen G Hoal; Craig J Kinnear; Marlo Möller
Journal:  Hum Genomics       Date:  2019-01-08       Impact factor: 4.639

8.  Clinical predictors for severe sepsis in patients with necrotizing fasciitis: an observational cohort study in northern Thailand.

Authors:  Patcharin Khamnuan; Wilaiwan Chongruksut; Kijja Jearwattanakanok; Jayanton Patumanond; Apichat Tantraworasin
Journal:  Infect Drug Resist       Date:  2015-07-16       Impact factor: 4.003

9.  Pattern and predictors of mortality in necrotizing fasciitis patients in a single tertiary hospital.

Authors:  Gaby Jabbour; Ayman El-Menyar; Ruben Peralta; Nissar Shaikh; Husham Abdelrahman; Insolvisagan Natesa Mudali; Mohamed Ellabib; Hassan Al-Thani
Journal:  World J Emerg Surg       Date:  2016-08-08       Impact factor: 5.469

Review 10.  Vibrio vulnificus infection: a persistent threat to public health.

Authors:  Na Ra Yun; Dong-Min Kim
Journal:  Korean J Intern Med       Date:  2018-06-15       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.